Test Anxiety on Bowel Health and Constipation in Students
The Effect of Test Anxiety on Bowel Health and Constipation in University Students
This observational cross-sectional study aims to examine the relationship between test anxiety, bowel health, and constipation in university students. The study will include undergraduate students aged 18 years and older who are studying in the Physiotherapy and Rehabilitation Department at Lokman Hekim University and who are in their final examination period.
Participants will complete self-report questionnaires during a single face-to-face assessment session. Constipation status will be evaluated using the Rome IV criteria, stool form will be assessed using the Bristol Stool Scale, constipation severity will be assessed using the Constipation Severity Instrument, and test anxiety level will be assessed using the Test Anxiety Inventory. Sociodemographic characteristics and bowel-related symptoms will also be recorded.
The study does not include any intervention or treatment. The findings are expected to help better understand whether test anxiety during examination periods is associated with bowel health problems and constipation in university students.
Tutkimuksen yleiskatsaus
Tila
Interventio / Hoito
Yksityiskohtainen kuvaus
Constipation is a common gastrointestinal problem that may affect quality of life, daily activities, and psychosocial well-being. University students may be particularly vulnerable to bowel habit changes during examination periods because of increased academic stress and test-related anxiety.
This study is designed as an observational, cross-sectional, and analytical study. It will evaluate whether test anxiety is associated with bowel health indicators and constipation among university students during the final examination period. The study will be conducted at Lokman Hekim University with undergraduate students from the Department of Physiotherapy and Rehabilitation.
After providing informed consent, participants will complete self-report forms and questionnaires in a single face-to-face assessment session. The assessment will include questions about sociodemographic characteristics, bowel habits, bowel-related symptoms, constipation status, stool form, constipation severity, and test anxiety level. No intervention, treatment, randomization, or follow-up assessment will be performed.
The study is expected to provide information about the possible relationship between psychological stress related to examinations and bowel health in university students. The findings may contribute to a better understanding of stress-related bowel problems and may support future preventive approaches for young adults.
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Yhteystiedot ja paikat
Opiskeluyhteys
- Nimi: Demet Öztürk, Phd
- Puhelinnumero: +905068394288
- Sähköposti: demett.ozturkk@gmail.com
Tutki yhteystietojen varmuuskopiointi
- Nimi: Mustafa Sarı, Phd
- Puhelinnumero: +905068394288
- Sähköposti: mustafa.sari@lokmanhekim.edu.tr
Opiskelupaikat
-
-
Ankara
-
Ankara, Ankara, Turkki (Türkiye), 06510
- Rekrytointi
- Lokman Hekim University, Ankara, Ankara
-
Ottaa yhteyttä:
- Demet Öztürk, Phd
- Puhelinnumero: 05068394288
- Sähköposti: demett.ozturkk@gmail.com
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
- Lapsi
- Aikuinen
- Vanhempi Aikuinen
Hyväksyy terveitä vapaaehtoisia
Näytteenottomenetelmä
Tutkimusväestö
Kuvaus
Inclusion Criteria:
- Being an undergraduate student in the Department of Physiotherapy and Rehabilitation at Lokman Hekim University
- Being in the final examination period during the data collection process
- Having sufficient reading and comprehension skills to complete the questionnaires independently
- Voluntarily agreeing to participate in the study after reading and signing the informed consent form
Exclusion Criteria:
- Having inflammatory bowel disease, such as Crohn's disease or ulcerative colitis, celiac disease, colorectal cancer, or a history of major gastrointestinal surgery
- Having diagnosed irritable bowel syndrome or another organic gastrointestinal disease
- Regular use of laxatives or medications that directly affect bowel movements, such as opioids
- Having neurological diseases that may affect bowel function, such as multiple sclerosis, Parkinson's disease, or spinal cord injury
- Having had an acute gastrointestinal infection within the last month
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
Kohortit ja interventiot
Ryhmä/Kohortti |
Interventio / Hoito |
|---|---|
|
University Students
Undergraduate students aged 18 years and older who are studying in the Department of Physiotherapy and Rehabilitation at Lokman Hekim University and who are in their final examination period.
Participants will complete self-report questionnaires assessing test anxiety, bowel habits, stool form, constipation status, and constipation severity during a single face-to-face assessment session.
|
Osallistujat täyttivät arviointilomakkeita ja päiväkirjoja.
Interventiota ei toteutettu.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Constipation Status Assessed by the Rome IV Criteria
Aikaikkuna: Baseline (Day 1)
|
Constipation status will be assessed using the Rome IV criteria.
This outcome will be reported as a binary classification: presence or absence of constipation.
Participants will be classified as having constipation or not having constipation according to constipation-related symptoms, including reduced stool frequency, straining, hard stools, sensation of incomplete evacuation, sensation of anorectal obstruction, and need for manual maneuvers.
The Rome IV criteria will not be reported as a scale score.
|
Baseline (Day 1)
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Constipation Severity Assessed by the Constipation Severity Instrument
Aikaikkuna: Baseline (Day 1)
|
Constipation severity will be assessed using the Constipation Severity Instrument.
The scale includes 16 items and evaluates constipation-related symptoms across three subdomains: obstructive defecation, colonic inertia, and pain.
The total score ranges from 0 to 73, with higher scores indicating more severe constipation symptoms.
|
Baseline (Day 1)
|
|
Stool Form Assessed by the Bristol Stool Scale
Aikaikkuna: Baseline (Day 1)
|
Stool form will be assessed using the Bristol Stool Scale.
The Bristol Stool Scale is a 7-point stool form classification scale ranging from Type 1 to Type 7. Type 1 indicates separate hard lumps, and Type 7 indicates watery stool with no solid pieces.
Higher scores do not indicate a better or worse outcome; lower scores generally indicate harder stool forms, while higher scores indicate looser stool forms.
Participants will be asked to select the stool type that best represents their most common stool form during the last week.
|
Baseline (Day 1)
|
|
Test Anxiety Level Assessed by the Test Anxiety Inventory
Aikaikkuna: Baseline (Day 1)
|
Test anxiety level will be assessed using the Test Anxiety Inventory.
The scale consists of 20 self-report items evaluating cognitive, emotional, and physiological symptoms of anxiety experienced before and during examinations.
Total scores range from 20 to 80, with higher scores indicating higher test anxiety.
|
Baseline (Day 1)
|
|
Bowel Habits and Bowel-Related Symptoms
Aikaikkuna: Baseline (Day 1)
|
Bowel habits and bowel-related symptoms will be assessed using a researcher-developed evaluation form.
The form includes questions about stool frequency, postponement of defecation, perceived bowel health, preferred toilet type, and symptoms such as abdominal pain, bloating, gas, diarrhea, nausea, vomiting, indigestion, and constipation during the last week.
|
Baseline (Day 1)
|
Yhteistyökumppanit ja tutkijat
Sponsori
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- 2026032
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .